Publications by authors named "Colin Baigent"

Claim this Profile
E
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.
William G Herrington, Zhaojing J Che, Rebecca Sardell, Alistair J Roddick, Parminder K Judge, Colin Baigent

Lancet Diabetes Endocrinol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Doreen Zhu, Parminder K Judge, Susan T Francis, Zhaojing Che, Jennifer J Rayner, Colin Baigent

Am J Kidney Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.
François Mach, Konstantinos C Koskinas, Jeanine E Roeters van Lennep, Lale Tokgözoğlu, Lina Badimon, Colin Baigent

Eur Heart J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating the long-term effects of aspirin for primary prevention.
Colin Baigent, Alistair Roddick, Carlo Patrono

Eur Heart J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias].
François Mach, Konstantinos C Koskinas, Jeanine E Roeters van Lennep, Lale Tokgözoğlu, Lina Badimon, Colin Baigent

G Ital Cardiol (Rome)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition.
Greco B Malijan, Daniel Chapman, Stewart Moffat, Rebecca J Sardell, Natalie Staplin, Colin Baigent

Kidney Int Rep· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias.
François Mach, Konstantinos C Koskinas, Jeanine E Roeters van Lennep, Lale Tokgözoğlu, Lina Badimon, Colin Baigent

Atherosclerosis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Greco B Malijan, Rebecca J Sardell, Natalie Staplin, Olivier Devuyst, Daniel Chapman, Colin Baigent

Am J Kidney Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balancing the risk of major bleeding against vascular disease risk in people without atherosclerotic disease.
Imen Hammami, Marion Mafham, Jonathan Emberson, Alison Offer, Jemma C Hopewell, Colin Baigent

Heart· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Junwen Zhou, Claire Williams, Natalie Staplin, Parminder K Judge, Kaitlin J Mayne, Colin Baigent

EClinicalMedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
Parminder K Judge, Katherine R Tuttle, Natalie Staplin, Sibylle J Hauske, Doreen Zhu, Colin Baigent

Nephrol Dial Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations I: therapy and prevention.
Peter Jüni, Sotiris Antoniou, Elena Arbelo, Sergio Buccheri, Maja Cikes, Colin Baigent

Eur Heart J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2024 Revision of the level of evidence grading system for ESC clinical practice guideline recommendations II: diagnostic tests and prediction models.
Emanuele Di Angelantonio, Lisa Pennells, Magdy Abdelhamid, Victor Aboyans, Riccardo Asteggiano, Colin Baigent

Eur Heart J· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, Parminder K Judge, Doreen Zhu, Colin Baigent

Nephrol Dial Transplant· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.

N Engl J Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing long-term effectiveness and cost-effectiveness of statin therapy in the UK: a modelling study using individual participant data sets.
Borislava Mihaylova, Runguo Wu, Junwen Zhou, Claire Williams, Iryna Schlackow, Colin Baigent

Health Technol Assess· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study.
Borislava Mihaylova, Runguo Wu, Junwen Zhou, Claire Williams, Iryna Schlackow, Colin Baigent

Heart· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Kaitlin J Mayne, Rebecca J Sardell, Natalie Staplin, Parminder K Judge, Doreen Zhu, Colin Baigent

Clin J Am Soc Nephrol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A blunted nocturnal blood pressure decline is associated with all-cause and cardiovascular mortality.
Alejandro de la Sierra, Natalie Staplin, Luis M Ruilope, Manuel Gorostidi, Ernest Vinyoles, Colin Baigent

J Hypertens· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime effects and cost-effectiveness of standard and higher-intensity statin therapy across population categories in the UK: a microsimulation modelling study.
Borislava Mihaylova, Runguo Wu, Junwen Zhou, Claire Williams, Iryna Schlackow, Colin Baigent

Lancet Reg Health Eur· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial.
Giovanna Petrucci, Georgina A Buck, Bianca Rocca, Sarah Parish, Colin Baigent

Eur Heart J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term cardiovascular risks and the impact of statin treatment on socioeconomic inequalities: a microsimulation model.
Runguo Wu, Claire Williams, Junwen Zhou, Iryna Schlackow, Jonathan Emberson, Colin Baigent

Br J Gen Pract· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambulatory blood pressure monitoring and mortality - Authors' reply.
Alejandro de la Sierra, Natalie Staplin, Luis M Ruilope, Colin Baigent, Bryan Williams

Lancet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
Kaitlin J Mayne, Natalie Staplin, David F Keane, Christoph Wanner, Susanne Brenner, Colin Baigent

J Am Soc Nephrol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revascularization of low-surgical risk patients with disease of the left main coronary artery: a fresh look at the evidence.
Colin Baigent, Rafael Sádaba

Eur J Cardiothorac Surg· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis